- Home
- PED vs MURA Comparison
PED vs MURA Comparison
Compare PED & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- MURA
- Stock Information
- Founded
- PED N/A
- MURA 2013
- Country
- PED United States
- MURA Ireland
- Employees
- PED N/A
- MURA N/A
- Industry
- PED Oil & Gas Production
- MURA
- Sector
- PED Energy
- MURA
- Exchange
- PED Nasdaq
- MURA Nasdaq
- Market Cap
- PED 48.8M
- MURA 45.8M
- IPO Year
- PED N/A
- MURA N/A
- Fundamental
- Price
- PED $0.65
- MURA $2.25
- Analyst Decision
- PED Strong Buy
- MURA Strong Buy
- Analyst Count
- PED 1
- MURA 3
- Target Price
- PED $1.50
- MURA $12.00
- AVG Volume (30 Days)
- PED 124.9K
- MURA 79.4K
- Earning Date
- PED 08-13-2025
- MURA 08-12-2025
- Dividend Yield
- PED N/A
- MURA N/A
- EPS Growth
- PED 2248.88
- MURA N/A
- EPS
- PED 0.19
- MURA N/A
- Revenue
- PED $40,173,000.00
- MURA N/A
- Revenue This Year
- PED N/A
- MURA N/A
- Revenue Next Year
- PED $5.99
- MURA N/A
- P/E Ratio
- PED $3.50
- MURA N/A
- Revenue Growth
- PED 30.70
- MURA N/A
- 52 Week Low
- PED $0.47
- MURA $0.95
- 52 Week High
- PED $1.07
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- PED 51.19
- MURA 30.32
- Support Level
- PED $0.62
- MURA $2.42
- Resistance Level
- PED $0.69
- MURA $2.54
- Average True Range (ATR)
- PED 0.03
- MURA 0.08
- MACD
- PED 0.00
- MURA -0.02
- Stochastic Oscillator
- PED 43.00
- MURA 17.72
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.